Who Owns Scilex Stock?
NASDAQ: SCLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 2.88 -2.81%
Ownership breakdown
- Held by institutions
- 8.51%
- Held by insiders
- 11.66%
- Institutional holders
- 96
- Institutions 8.5%
- Insiders 11.7%
- Public and other 79.8%
Who owns Scilex stock?
Institutional investors own about 8.5% of Scilex's shares, spread across 96 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 11.66% of SCLX.
The largest institutional holders are Vanguard Capital Management LLC (3.55%), Blackrock Inc. (1.29%) and Vanguard Fiduciary Trust Co (0.54%). Together, the top 10 institutions control 7.8% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their SCLX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SCLX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 301.29K | 3.55% | +14.1% |
| Blackrock Inc. | 109.42K | 1.29% | +6.4% |
| Vanguard Fiduciary Trust Co | 45.82K | 0.54% | +15.5% |
| Jacobs Levy Equity Management, Inc. | 41.16K | 0.48% | +100.0% |
| State Street Corporation | 35.38K | 0.42% | 0.0% |
| UBS Group AG | 33.38K | 0.39% | +416.0% |
| Renaissance Technologies, LLC | 33.06K | 0.39% | -10.3% |
| Citadel Advisors Llc | 27.50K | 0.32% | +100.0% |
| Price (T.Rowe) Associates Inc | 20.92K | 0.25% | +100.0% |
| Ashton Thomas Private Wealth, LLC | 18.48K | 0.22% | +2.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SCLX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 217.51K | 2.56% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 76.23K | 0.90% |
| iShares Trust-iShares Micro-Cap ETF | 23.93K | 0.28% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 14.02K | 0.17% |
| T. ROWE PRICE INDEX TRT, INC.-T. Rowe Price Extended Eqy. Market Index | 6.90K | 0.08% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 3.81K | 0.04% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 3.75K | 0.04% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 1.68K | 0.02% |
| Brighthouse Funds Trust II-MetLife Russell 2000 Index Portfolio | 627 | 0.01% |
| STATE STREET Inst. INVESTMENT TRT-State Street Balncd Index Fd. | 120 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Scilex?
Vanguard Capital Management LLC is the largest institutional shareholder of SCLX, owning 3.55% of shares outstanding (301.29K shares) as of its latest 13F filing.
What percentage of Scilex is owned by institutions?
Institutions own about 8.5% of SCLX shares and 9.6% of the public float.
How much of Scilex do insiders own?
Insiders, such as officers and directors, own about 11.66% of SCLX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.